Amphenol Treasury Stock increased by 110.6% to $220.90M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 6.8%, from $236.90M to $220.90M. Over 4 years (FY 2020 to FY 2024), Treasury Stock shows an upward trend with a 15.8% CAGR.
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
treasury_stock| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $100.10M | $89.30M | $100.00M | $101.00M | $92.00M | $97.50M | $79.80M | $69.70M | $49.60M | $170.60M | $142.80M | $103.80M | $73.80M | $236.90M | $199.70M | $174.00M | $104.90M | $220.90M |
| QoQ Change | — | -10.8% | +12.0% | +1.0% | -8.9% | +6.0% | -18.2% | -12.7% | -28.8% | +244.0% | -16.3% | -27.3% | -28.9% | +221.0% | -15.7% | -12.9% | -39.7% | +110.6% |
| YoY Change | — | — | — | — | -8.1% | +9.2% | -20.2% | -31.0% | -46.1% | +75.0% | +78.9% | +48.9% | +48.8% | +38.9% | +39.8% | +67.6% | +42.1% | -6.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.